That’s not fool in the motley sense, just foolish. I realise, having just become an irregular after a year or two on the sidelines, that DR KSS has described me exactly when talking about what NOT to do with small biotech stocks, i.e. buy them on the advice of exuberant newsletters without talking to anyone first!
Specifically, I hold
1. ATNM, which I now accept, after reading the long article from a year ago, is a bad idea, especially after the plunge caused by the recent issue of more stock. Advice please: get out now, or await minor plunge correction?
2. MBVX. Can’t find anything on here. Any opinions?
3. XXII. This one’s been OK, but now I read that suggestion from Dr KSS to cash in anything over 25% and see about a lower re-entry later. Again, ideas welcome!
Thanks and best wishes from Barcelona
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.